Cannagistics Inc
Cannagistics, Inc. develops, markets, and sells OTC, pharmaceutical, nutraceutical, cosmetic, and health and wellness products. Its product portfolio includes Canagel, an anhydrous hydrogel composition and delivery system; Silverpro, a compression fabric; KidzStrips, a thin film children's toothpaste strip; and ImmuniZin, an immune booster, as well as HydroSoil, a novel fertilizer. The company al… Read more
Cannagistics Inc (CNGT) - Net Assets
Latest net assets as of July 2022: $-6.62 Million USD
Based on the latest financial reports, Cannagistics Inc (CNGT) has net assets worth $-6.62 Million USD as of July 2022.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($81.60K) and total liabilities ($6.71 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-6.62 Million |
| % of Total Assets | -8117.43% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 1102.8 |
Cannagistics Inc - Net Assets Trend (2005–2022)
This chart illustrates how Cannagistics Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cannagistics Inc (2005–2022)
The table below shows the annual net assets of Cannagistics Inc from 2005 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-07-31 | $-5.65 Million | 0.00% |
| 2021-07-31 | $-5.65 Million | -21.15% |
| 2020-07-31 | $-4.66 Million | -50.32% |
| 2019-07-31 | $-3.10 Million | -165.11% |
| 2018-07-31 | $-1.17 Million | -215.34% |
| 2017-07-31 | $1.01 Million | 0.00% |
| 2016-07-31 | $1.01 Million | +313.03% |
| 2015-07-31 | $-476.02K | -33.03% |
| 2014-07-31 | $-357.84K | -37.99% |
| 2008-07-31 | $-259.32K | -2685.73% |
| 2007-07-31 | $10.03K | -77.15% |
| 2006-07-31 | $43.88K | +391.69% |
| 2005-07-31 | $8.93K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cannagistics Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1558661600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (July 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $189.56K | % |
| Other Comprehensive Income | $290.00K | % |
| Other Components | $9.49 Million | % |
| Total Equity | $-5.65 Million | 100.00% |
Cannagistics Inc Competitors by Market Cap
The table below lists competitors of Cannagistics Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Food Culture Inc.
PINK:FCUL
|
$25.89K |
|
Wins Finance Holdings Inc
PINK:WINSF
|
$25.89K |
|
MDPLF
PINK:MDPLF
|
$25.91K |
|
DONGFANG ELEC -H-
BE:DEU
|
$25.92K |
|
Piquadro SpA
STU:4LZ
|
$25.84K |
|
DIAC SALAF
BC:DIAC-SALAF
|
$25.83K |
|
VULC3F
SA:VULC3F
|
$25.81K |
|
AltEnergy Acquisition Corp. Warrant
NASDAQ:AEAEW
|
$25.81K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cannagistics Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from -5,646,703 to -5,646,703, a change of 0.
- Net loss of 2,976,857 reduced equity.
- Other factors increased equity by 2,976,857.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-2.98 Million | -52.72% |
| Other Changes | $2.98 Million | +52.72% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Cannagistics Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-07-31 | $3.24 | $0.00 | x |
| 2006-07-31 | $2.65 | $0.00 | x |
| 2007-07-31 | $0.59 | $0.00 | x |
| 2008-07-31 | $-15.13 | $0.00 | x |
| 2012-07-31 | $-18.50 | $0.00 | x |
| 2013-07-31 | $-8.33 | $0.00 | x |
| 2014-07-31 | $-0.86 | $0.00 | x |
| 2015-07-31 | $-0.62 | $0.00 | x |
| 2017-07-31 | $0.60 | $0.00 | x |
| 2018-07-31 | $-0.09 | $0.00 | x |
| 2019-07-31 | $-0.12 | $0.00 | x |
| 2020-07-31 | $-0.05 | $0.00 | x |
| 2021-07-31 | $-0.04 | $0.00 | x |
| 2022-07-31 | $-0.04 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cannagistics Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-1017.61%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | -241.02% | 0.00% | 0.00x | 1.74x | $-22.40K |
| 2006 | -57.07% | 0.00% | 0.00x | 1.39x | $-29.43K |
| 2007 | -1965.91% | 0.00% | 0.00x | 11.41x | $-198.16K |
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-370.42K |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $357.00K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $26.07K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-53.57K |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-608.60K |
| 2016 | -6500.05% | -878868.93% | 0.01x | 1.30x | $-66.02 Million |
| 2017 | -6500.05% | -878868.93% | 0.01x | 1.30x | $-66.02 Million |
| 2018 | 0.00% | -1595.82% | 3.47x | 0.00x | $-13.07 Million |
| 2019 | 0.00% | -168.64% | 3.20x | 0.00x | $-3.62 Million |
| 2020 | 0.00% | -124.53% | 39.63x | 0.00x | $-2.44 Million |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.41 Million |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.41 Million |
Industry Comparison
This section compares Cannagistics Inc's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cannagistics Inc (CNGT) | $-6.62 Million | -241.02% | N/A | $25.87K |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |